Prices delayed by at least 15 minutes | Print
UBS (Irl) Etf PLC UBS MSCI USA PRIME VAL SCRND ETF USD
Open
3,293.00p
Previous close
3,273.50p
Trade high
3,293.00p
Income frequency
-
Year low
2,812.00p
Year high
3,300.00p
Replication method
Physical Full
Volume
0
Type
ETF
UCITS
Yes
Dividend yield
1.24%
Ongoing charge
0.25
ISIN
IE00BX7RR706
Share price
Asset allocation
Top 10 holdings
| Holdings 10/11/2026 | % of assets |
|---|---|
| Berkshire Hathaway Inc Class B | 3.29 |
| Merck & Co Inc | 2.96 |
| UnitedHealth Group Inc | 2.49 |
| International Business Machines Corp | 2.39 |
| Pfizer Inc | 2.38 |
| Accenture PLC Class A | 2.35 |
| Texas Instruments Inc | 2.26 |
| Cisco Systems Inc | 2.16 |
| The Walt Disney Co | 2.16 |
| Applied Materials Inc | 2.15 |
Investment objective
The Fund seek to track the alternatively weighted equity market performance of the US market.The investment policy of the Fund is to seek to track the performance of the MSCI USA Prime Value Advanced Target Select Index (Net Total Return) (or any other index determined by the Directors from time to time to track substantially the same market as the MSCI USA Prime Value Advanced Target Select Index (Net Total Return) and which is considered by the Directors to be an appropriate index for the Fund to track) as closely as possible, while seeking to minimise as far as possible the difference in performance between the Fund and the Index.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.